Molecular genetics & genomic medicine · 2026
A Rare Clinical Presentation of Variegate Porphyria.
СтатьяКлинический случайНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Viakhireva I, Murtazina A, Orlova A, Makretskaya N, Nikitin S, Skoblov M
Аннотация
BACKGROUND: Variegate porphyria is a rare heme biosynthesis disorder caused by pathogenic variants in the PPOX gene. Despite being relatively well characterized, its clinical manifestations are highly variable and can mimic a broad spectrum of neurological and systemic conditions.
CASE PRESENTATION: We report the case of a young woman with recurrent episodes of muscle weakness, sometimes accompanied by respiratory dysfunction. Initially suspected to have myasthenia gravis, laboratory testing for this condition was negative. Whole-genome sequencing identified a heterozygous pathogenic variant c.338G>C in the PPOX gene and a homozygous variant of uncertain significance c.190G>A in MYMK, with no other disease-causing variants detected in genes associated with congenital myasthenic syndromes or periodic paralysis.
CONCLUSION: In the described case, the patient's atypical clinical manifestations led to a prolonged and complex diagnostic workup. WGS findings suggested possible co-occurrence of variegate porphyria with a potential overlap with a Carey-Fineman-Ziter syndrome. This case highlights the importance of comprehensive evaluation of the clinical presentation in patients with unexplained neuromuscular symptoms.
CASE PRESENTATION: We report the case of a young woman with recurrent episodes of muscle weakness, sometimes accompanied by respiratory dysfunction. Initially suspected to have myasthenia gravis, laboratory testing for this condition was negative. Whole-genome sequencing identified a heterozygous pathogenic variant c.338G>C in the PPOX gene and a homozygous variant of uncertain significance c.190G>A in MYMK, with no other disease-causing variants detected in genes associated with congenital myasthenic syndromes or periodic paralysis.
CONCLUSION: In the described case, the patient's atypical clinical manifestations led to a prolonged and complex diagnostic workup. WGS findings suggested possible co-occurrence of variegate porphyria with a potential overlap with a Carey-Fineman-Ziter syndrome. This case highlights the importance of comprehensive evaluation of the clinical presentation in patients with unexplained neuromuscular symptoms.